한국어
Quantus

CosLeaguer Global

043710 · KOSDAQ
₩3,245+5.70%
2026-09-04 close

CosLeaguer Global last closed at ₩3,245 (+5.70%) on 2026-09-04. Signals today: MACD bullish cross. Listed on KOSDAQ; price, financials and dividends update daily after market close.

Loading chart…
Close
No active signal.

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
303 picks
Next-day win rate
50.7%
Avg next-day
-0.11%
vs market
-0.49%p

Every new-high-plus-volume pick we actually published (Korea market) — not this stock alone.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

D
Overall: 건강관리 255/291 · top 88%
Factor composite · relative position in sector

PER 10.44 · PBR 1.44 — own-history percentile 97/100 · 60/100

Open self-history band
PER97/100
PBR60/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2024
Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 2.87
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
2.87
Beneish M-Score
-2.22

No statistical flag

Sloan accrual
11.30%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

5/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score5/9

Profitability

  • Positive ROAPass
  • Positive OCFNot passed
  • Improving ΔROAPass
  • Accruals (OCF > net income)Not passed

Leverage & liquidity

  • Lower debtPass
  • Higher current ratioNot passed
  • No new sharesPass

Efficiency

  • Higher gross marginPass
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Margin trendWarning

영업외손익 급변 (영업이익 대비 1847% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Industry structure

KRAs of 2026-09-05

건강관리

This stock is in 건강관리: revenue rank 208 of 287, share 0%.

208 / 2870%revenue share

Who dominates this industry?

  1. 1삼성바이오로직스7.3%
  2. 2셀트리온5.7%
  3. 3녹십자홀딩스3.5%
  4. 4유한양행3.3%
  5. 5대웅3.1%
  6. 6코스리거글로벌0%

Concentration

DistributedCR3 16.6%
HHI 202287 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

Winner-take-all deepeningConsistent

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p
31.61
Direction
확대
Level
넓음
Years
7

Value lens

P90/P10
13.9
Median P/B
1.47
Level
넓음
n
263

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
-1.2%
Interest coverage
-0.4x
Return on equity (ROE)
13.8%

Operating margin −5pp

Operating loss
Interest coverageBase -0.4x adverse case -2.2x
Return on equity (ROE)Base 13.8% adverse case -4.5%

Revenue −15%

Interest coverage risk
Interest coverageBase -0.4x adverse case -0.4x
Return on equity (ROE)Base 13.8% adverse case -1.9%

Interest rate +2pp

Interest coverage risk
Interest coverageBase -0.4x adverse case -0.3x
Return on equity (ROE)Base 13.8% adverse case -2.6%

Interest coverage limit

Already below the limit by 4.1pp

Interest coverage limit at an operating margin of 2.9%

Interest expense coverage threshold

Key suppliers · Annual report

Annual reportDART · 2026-03-18

Suppliers disclosed by the company in its 2026-03-18 annual report.

Purchase amount

KRW 100m
  1. Oleifera
    KRW 19.4T
  2. Phytorex
    KRW 19.4T
  3. BUTYLENE
    KRW 15T
  4. GLYCOL
    KRW 15T
  5. CELLULOSE
    KRW 13.2T
  6. NATURAL
    KRW 13.2T
  7. AMPHISOL
    KRW 13.1T
  8. ALLANTOIN
    KRW 12.3T
  9. Biotin
    KRW 11.7T

Suppliers without disclosed amount

COHDEthanolPALMERAREFINEDGLYCERINE

Who held it · filings

Filed record

A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.

US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.

5%+ major-holding disclosures

  • 세심68.58%2026-08-05 · 증감 -8.50%p

Connections

AI-extracted related companies · for reference

Competitors
카카오모빌리티티머니우버리프트
Same theme
구글
🔗 See in the full market map →

Recent filings

CosLeaguer Global's latest filings on Korea's DART. Open a headline for a reference summary and the original.

Source: DART (Korea electronic disclosure)

About CosLeaguer Global
What technical signals does CosLeaguer Global (043710) have?
CosLeaguer Global current technical signals: no active technical signal.
Is CosLeaguer Global a cup-and-handle pattern?
No. CosLeaguer Global has no valid cup-and-handle signal right now.
What are CosLeaguer Global's financials and valuation?
CosLeaguer Global's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy